European Approval Granted for Moderna's Combination Flu and Covid Vaccine

European regulators have given the green light to Moderna's innovative flu and Covid-19 combination vaccine. Bloomberg posted on X, highlighting this development as a significant win for Moderna, which has encountered substantial opposition to its new vaccines in the United States. The approval marks a pivotal moment for the company as it seeks to expand its market presence amid challenges in the U.S. vaccine landscape. Moderna's efforts to introduce novel immunizations have faced hurdles, but the European endorsement could bolster its position in the global vaccine market.